MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1

Our previous study found that miR-652-3p is markedly upregulated in the serum of patients with NSCLC and suggesting that miR-652-3p is a potential biomarker for the early diagnosis of NSCLC. In this study, we detected the expression of miR-652-3p in NSCLC tumor tissues and cell lines and investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenhui, Zhou, Chengcheng, Luo, Mei, Shi, Xuejiao, Li, Yuan, Sun, Zengmiao, Zhou, Fang, Chen, Zhaoli, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941345/
https://www.ncbi.nlm.nih.gov/pubmed/26934648
http://dx.doi.org/10.18632/oncotarget.7697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941345/
https://www.ncbi.nlm.nih.gov/pubmed/26934648
http://dx.doi.org/10.18632/oncotarget.7697

Ejemplares similares